[HTML][HTML] Impact of new drugs for therapeutic intervention in Alzheimer's disease
J Olloquequi, M Ettcheto, A Cano… - Frontiers in Bioscience …, 2022 - imrpress.com
The increases in population ageing and growth are leading to a boosting in the number of
people living with dementia, Alzheimer's disease (AD) being the most common cause. In …
people living with dementia, Alzheimer's disease (AD) being the most common cause. In …
Alzheimer's disease; a review of the pathophysiological basis and therapeutic interventions
A Abeysinghe, R Deshapriya, C Udawatte - Life sciences, 2020 - Elsevier
Alzheimer's disease (AD) is a neurodegenerative disorder and is identified as the most
common cause for dementia. Despite huge global economic burden and the impact on the …
common cause for dementia. Despite huge global economic burden and the impact on the …
Novel therapeutic approaches for Alzheimer's disease: an updated review
Alzheimer's disease (AD) is a progressive neurodegenerative disease and accounts for
most cases of dementia. The prevalence of AD has increased in the current rapidly aging …
most cases of dementia. The prevalence of AD has increased in the current rapidly aging …
Alzheimer's disease hypothesis and related therapies
X Du, X Wang, M Geng - Translational neurodegeneration, 2018 - Springer
Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most
common cause for dementia. There are many hypotheses about AD, including abnormal …
common cause for dementia. There are many hypotheses about AD, including abnormal …
Comprehensive review on Alzheimer's disease: causes and treatment
Z Breijyeh, R Karaman - Molecules, 2020 - mdpi.com
Alzheimer's disease (AD) is a disorder that causes degeneration of the cells in the brain and
it is the main cause of dementia, which is characterized by a decline in thinking and …
it is the main cause of dementia, which is characterized by a decline in thinking and …
[HTML][HTML] Small-molecule drugs development for Alzheimer's disease
W Yao, H Yang, J Yang - Frontiers in Aging Neuroscience, 2022 - frontiersin.org
Alzheimer's disease (AD) is an irreversible, progressive neurodegenerative brain disorder
with no effective therapeutic drugs currently. The complicated pathophysiology of AD is not …
with no effective therapeutic drugs currently. The complicated pathophysiology of AD is not …
Challenges in the treatment of Alzheimer's disease: recent progress and treatment strategies of pharmaceuticals targeting notable pathological factors
Introduction: Alzheimer's disease (AD), a commonly encountered neurodegenerative
disorder, causes cognitive decline and has a devastating effect on the quality of life. AD …
disorder, causes cognitive decline and has a devastating effect on the quality of life. AD …
Alzheimer's disease: molecular aspects and treatment opportunities using herbal drugs
Abstract Alzheimer's disease (AD), also called senile dementia, is the most common
neurological disorder. Around 50 million people, mostly of advanced age, are suffering from …
neurological disorder. Around 50 million people, mostly of advanced age, are suffering from …
Recent update on the Alzheimer's disease progression, diagnosis and treatment approaches
Alzheimer's disease (AD) is a multifactorial, progressive, neurodegenerative disorder,
manifested by the loss of memory and cognitive abilities, behavioral disturbance and …
manifested by the loss of memory and cognitive abilities, behavioral disturbance and …
An update on pharmacological approaches to neurodegenerative diseases
Neurodegenerative diseases are now generally considered as a group of disorders that
seriously and progressively impair the functions of the nervous system through selective …
seriously and progressively impair the functions of the nervous system through selective …